ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 147 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,734 | -19.8% | 4,578 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $17,122 | -27.8% | 4,578 | -7.1% | 0.00% | 0.0% |
| Q4 2022 | $23,704 | -15.5% | 4,928 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $28,040 | -19.9% | 4,928 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $34,989 | -1.7% | 4,928 | 0.0% | 0.00% | +100.0% |
| Q1 2022 | $35,580 | -78.9% | 4,928 | -73.9% | 0.00% | -50.0% |
| Q4 2021 | $168,707 | -74.5% | 18,871 | 0.0% | 0.00% | -80.0% |
| Q3 2021 | $661,617 | +131.9% | 18,871 | +308.4% | 0.01% | +150.0% |
| Q1 2021 | $285,347 | +40.9% | 4,621 | -4.7% | 0.00% | +33.3% |
| Q4 2020 | $202,508 | – | 4,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |